Monthly Archives: May 2017

CEA Antibodies Market – Global Industry Analysis and Forecast 2015 – 2023

CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in nature is 0 micrograms to 0.25 micrograms per liter of blood. Elevated levels of carcinoembryonic antigen in patients recently treated for cancer, indicates recurrence of the cancer.

Obtain Report Details @
http://www.transparencymarketresearch.com/cea-antibodies-market.html

The elevated levels of carcinoembryonic antigens results in different types of cancers and other conditions such as cholecystitis, lung infection, heavy smoking, inflammatory bowel diseases, peptic and ulcer. High level of carcinoembryonic antigens is also found in the patients who are not diagnosed with cancer. This increases the risk of developing cancer in such patients. Hematoma (blood accumulating under the skin), infection, dizziness and excessive bleeding are some of the risks associated with abnormal levels of CEA. The abnormal levels of CEA in the body can be detected by using arcitumomab, a monoclonal antibody. This is commonly utilized in identification of glycoprotein expression in tissue samples. CEA antibody acts against the CEA, and help treat patients with presence of CEA protein. Hence, this antibody in utilized extensively to treat the patients suffering from CEA associated cancers.

Several drugs (CEA antibody) are currently available in the market that are utilized to treat CEA cancer. Pan CEA and clone II-7 are some of the examples of CEA antibody drugs. Discovery of specific antigens and biomarkers propels the growth of carcinoembryonic antigen antibody market. Similarly, continuous technological advancements in the drugs will also augment the growth of carcinoembryonic antigen antibody market. Likewise, rise in geriatric population also supports the growth of carcinoembryonic antigen antibody market. This is due to the fact that this class of population is at higher risk for developing CEA associated cancers. The World Health of Organization has estimated that by 2050, around 2 billion people belong to this population. However, lack of awareness and availability of novel technological solutions might pose a challenge to the growth of CEA antibody market.

In 2012, North America accounted for the largest share of the global carcinoembryonic antigen antibody market. This is due to the presence of large number of companies engaged in developing and manufacturing carcinoembryonic antigen antibodies. Also, increasing R&D expenditure by various players in the region will augment the growth of carcinoembryonic antigen antibody market. Likewise, increasing government initiatives regarding the development of carcinoembryonic antigen antibody will further accentuate the growth of carcinoembryonic antigen antibody market. Europe accounted for the second largest share by revenue in 2012 of global carcinoembryonic antigen antibody market. This large market revenue is attributed to the presence of large geriatric population coupled with increasing healthcare expenditure in the region. Asia-Pacific along with Rest of the World (RoW) contributed smallest share in the global carcinoembryonic antigen antibody market in 2012. Lack of awareness coupled with presence of few pharmaceutical companies that are engaged in developing and manufacturing carcinoembryonic antigen antibodies restrict the growth of carcinoembryonic antigen antibody market in these two regions of the globe.

Some of the major players operating in the carcinoembryonic antigen antibody market include Abbott Laboratories, Siemens Healthcare, bioMerieux, Danaher Corporation (Beckman Coulter), Myriad Genetics, Epigenomics, Qiagen N.V., and Life Technologies Corporation among other significant players.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4682

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Advertisements

Neuroprosthetics Market Global Industry Volume By Region 2015 – 2023

Global Neuroprosthetics Market: Overview 

Neuroprosthetics, or more commonly as neural or brain implants, have added a noteworthy impetus to the healthcare industry over the past few years, thanks to the successful realization of its massive potential as a substitution method for injured or missing motor, sensory, or cognitive functions. Neuroprosthetic devices can develop or supplant the central nervous system’s function, when embedded in the human body, in order to stimulate organ function that was previously incomplete due to disease or injury. It is therefore a brain-computer interface device that can be used to sense and interpret neural activity into command sequences for prosthetics. The core function of neuroprosthetics is the rehabilitation of a patient’s motor functions through the restoration of the ones that are damaged. Several causes are listed under loss of motor skills, including injuries or diseases such as spinal cord injuries, multiple sclerosis, lateral sclerosis, and strokes.

This research report on the global neuroprosthetics market is a thorough reading of its present day trends, opportunities, drivers, and restraints. It arranges for projection within the global neuroprosthetics market for the given forecast period. This also include an examination of recent technological developments, along with the competitive development, which as explained using Porter’s Five Forces analysis. The report also includes reviews of the major and minor features that are indispensable for the current players in the global neuroprosthetics market and are viable tools for new entrants.

Obtain Report Details @
http://www.transparencymarketresearch.com/neuroprosthetics-market.html

Global Neuroprosthetics Market: Trends and Opportunities: 

The increasing patient count for neurological diseases in the world is currently the primary driver for the global neuroprosthetics market. A growing number of patients are being affected by diseases such as Parkinson’s which can severely hinder and complicate the daily life of an individual. One of the fundamental reasons for this increasing patient count is the swiftly increasing population of geriatric citizens. This growing elderly population has had a strong impact on this market and will continue to be a driving force for developments and technological implementations over the coming years.

The global neuroprosthetics market is also being propelled by other factors such as increasing awareness and availability of treatments across all regions, better reimbursement policies, improving government support, and increasing awareness initiatives by public and private bodies. Currently, however, the global neuroprosthetics market is being restricted by the limited reimbursement schemes in favor of the market, coupled with the high procedure cost which makes it out of reach for a large patient demographic.

Global Neuroprosthetics Market: Region-wise Outlook: 

The geographical segmentation of the global neuroprosthetics market is carried out through the key regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Among these core regions, the global neuroprosthetics market has been dominated by North America over the recent times. The North America healthcare industry holds a large spectrum of advanced technologies and key player headquarters, and a highly populated patient pool. Over the coming years, Asia Pacific is expected to rise at a phenomenal rate due to a booming healthcare industry in terms of outreach and infrastructure development, and the especially due to the increasing scope of medical tourism in this region. India and China are expected to be at the forefront of the expansion rate within the global neuroprosthetics market for the coming years.

Companies Mentioned in the Research Report: 

The key players in the global neuroprosthetics market over the recent times have included Cochlear Ltd., Boston Scientific Corporation, Cyberonics, Inc., Medtronic plc, NDI Medical LLC, NeuroPace, Inc., St. Jude Medical, Inc., Nervo Corp., Retina Implant AG, Biomet, Inc., and Sonova .

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4617

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Fosfomycin Calcium Market Analysis, Trends and Forecast by 2015 – 2023

Global Fosfomycin Calcium Market: Overview 

Fosfomycin calcium is a bactericidal agent with low toxicity levels and low cross-resistance level with other antibiotics. Known simply as fosfomycin or oral fosfomycin, it acts as an anti-infective agent by killing sensitive bacteria present in the affected body part. This substance exhibits high level of activity when used against gram positive and gram negative bacteria. White or yellow colored in the powdered form, fosfomycin can be used as an additive in drinking water and animal feed.

A clear, lucid analysis of the crucial factors accelerating and inhibiting the growth of the global market for fosfomycin calcium has been provided in the report. The major market trends and developments in the competitive landscape have been discussed, alongside a detailed analysis of the key market vendors and their business tactics such as partnerships, product innovation, and mergers. An analysis of the value chain, detailed descriptions of the key product and application segments, and market attractiveness are also included in the report.

Obtain Report Details @
http://www.transparencymarketresearch.com/fosfomycin-calcium-market.html

Global Fosfomycin Calcium Market: Drivers and Restraints 

Several studies such as clinical trials and case reports that incorporate data for patients of all ages, ranging from children to elderly populace suffering from disorders such as cystitis, pyelonephritis, gastrointestinal infections, and UTIs have revealed the efficiency of fosfomycin calcium. It has also been found to be useful in treating infections caused by several multidrug-resistant bacteria including penicillin-resistant pneumococci, vancomycin-resistant enterococci, and methicillin-resistant S.aureus. Tobramycin is used in combination with fosfomycin calcium in the treatment of lung infections in patients suffering from cystic fibrosis.

Moreover, when 28 patients with chronic sinusitis were administered with fosfomycin calcium as a nebulized treatment, it led to reduction of symptoms in 22 of them. Fosfomycin calcium can also be a viable alternative replacing fluoroquinolones in the treatment of chronic bacterial prostatitis, finds a small study that was presented at Interscience Conference on Antimicrobial Agents and Chemotherapy held in San Diego during 2015.

In this study conducted by Ilias Karaiskos, MD, from the Hygeia General Hospital in Greece, a daily dosage of 3gms for a week, and then 3gms per 48 hours for a 6 week period was given orally to 20 patients. 85% of these patients, displayed signs of improved or resolved infection.  The positive results of such research projects could pave the way for further expansion of the market in the future.

However, side effects such as nausea, dizziness, and gastrointestinal disturbances incurred by fosfomycin calcium-drugs might inhibit the growth of the global market for fosfomycin calcium. Nonetheless, the expansion of the market is assured by the ceaseless efforts of the market players who are attempting to explore the emerging markets.

Global Fosfomycin Calcium Market: Regional Outlook 

Asia Pacific, being the fastest growing region, promises considerable growth opportunities. India and China, exhibiting high demand for fosfomycin calcium are expected emerge as the key contributors to revenue generated by the Asia Pacific market. Countries such as Brazil, Germany, Japan, South Africa, France, and Spain have been using fosfomycin calcium on a large scale. North American region is also likely to register significant growth, thanks to the adoption of fosfomycin calcium in the treatment of uncomplicated urinary tract infection (UTI). Europe has also been displaying increasing demand for fosfomycin calcium, which is sold for oral use under different brand names.

Companies mentioned in the research report 

FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd., Ercros S.A., AdvaCare Pharma, China Sinopharm International Shanghai Co., Ltd., Serendex Pharmaceuticals A/S, Northeast Pharmaceutical Group Co., Ltd., SINTOFARM FARMACEUTICI S.p.A., and Mingshui Fukang Chemical Co., Ltd. are some of the major companies operating in the global market for fosfomycin calcium.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4511

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Protein Characterization and Identification Market Analysis, Trends and Forecast by 2015 – 2023

Global Protein Characterization and Identification Market: Overview 

Proteins form the fundamental component of human life and thus, they are an important subject of study and research. Protein characterization and identification is the basic research process to analyze the contents of a protein-based on their molecular weight and their charge. The demand for protein characterization and identification is high for clinical diagnosis, agricultural and environmental research, and drug discovery and development. The research process finds application across end-use sectors such as pharmaceutical, biotechnology, contract research organizations, and academic research institutes.

The report on the global protein characterization and identification market encompasses all the important parameters of the market and its affiliated industries. The key trends and opportunities presented in the report are useful for existing as well as new players in formulating viable growth strategies. Besides, the detailed coverage of business strategies and latest developments of the leading companies in the market makes the report a reliable business tool. The report also sheds light on market segmentation on the basis of various criteria, including geography and application.

Obtain Report Details @
http://www.transparencymarketresearch.com/protein-characterization-identification-market.html

Global Protein Characterization and Identification Market: Drivers and Restraints

To ensure sustainable growth, pharmaceutical and biotechnology companies are paying high attention to research and development activities. As a result, they are pouring large fund into such activities, which has a direct positive impact on the growth of the global protein characterization and identification market. In addition, rapid advancements in technology are facilitating improvements in research processes, thereby augmenting the market.

The robust growth of the biologics and proteomics sectors is also one of the key factors stoking the adoption of protein characterization and identification. Besides this, several governments worldwide are investing large sums in proteomics research, which is providing a fillip to the global market.

However, the high cost of instruments used in protein characterization and identification is acting as a major impediment to the growth of the market. Moreover, the dearth of skilled and qualified personnel is hindering the growth of the market. Nevertheless, the emergence of biomarkers along with the booming biomarker identification segment is rendering the global protein characterization and identification market highly lucrative.

Global Protein Characterization and Identification Market: Geographical Segmentation 

The key regions reviewed in the report are Asia Pacific, North America, Europe, and Rest of the World. Asia Pacific will be a prominent market for protein characterization and identification. The region is a home to a large number of companies manufacturing biotechnological analytical devices. The increasing investments by governments of emerging economies in research and development activities are leading to the greater uptake of protein electrophoresis equipment in the region. The growth of APAC can also be attributed to the easy availability of raw materials and reagents. Japan and China will be major revenue contributors to the growth of the market. Europe will also represent a large share in the market during the forecast period, with France and the U.K. being sights of high growth rate.

Global Protein Characterization and Identification Market: Competitive Landscape

The global protein characterization and identification market is a highly fragmented arena in nature. Research and development play a vital role in the protein characterization and identification industry. Therefore, companies are investing sizeable funds in these activities. In addition, players in the market are looking upon mergers and acquisitions as a viable strategy to enhance their research facilities. Some of the key participants in the global marketplace are Proteome Factory AG, CBS Scientific Company Inc., AB Sciex Pte. Ltd, Alphalyse Inc., LabRepCo., Serva Electrophoresis GmbH., Lonza Group Ltd, Sigma-Aldrich Co. LLC., and Hoefer Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4501

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Competitive Landscape for Global Collagenase Clostridium Histolyticum Market by Segments – 2024

Global Collagenase Clostridium Histolyticum Market: Overview

Collagenase clostridium histolyticum is primarily used in the treatment of Dupuytren’s contracture and Peyronie’s disease. Thus, the global market for collagenase clostridium histolyticum is gaining traction due to the rising prevalence of these two diseases, especially in developed countries. Collagenase is an enzyme that helps in breaking down the chord of thickened tissue and permits straightening of fingers. Some of the primary medications available in the market based on this enzyme are Xiapex (Europe), Xiaflex (U.S.), and Collagenase Santyl.

The report identifies and meticulously examines the trends and opportunities impacting the growth of the global collagenase clostridium histolyticum market. It extensively covers the entire value chain of the market along with the suppliers and distributor analysis. For a clear understanding, the report segments the market on the basis of geography and provides data for the market across each segment. The key players in the market are profiled along with their business strategies, market shares, latest developments, and revenue and cost structures. The report includes a separate section of recommendations by industrial experts for both established as well as emerging players in the collagenase clostridium histolyticum market.

Obtain Report Details @
http://www.transparencymarketresearch.com/collagenase-clostridium-histolyticum-market.html

Global Collagenase Clostridium Histolyticum Market: Drivers and Restraints

Besides their conventional use in the treatment of Peyronie’s disease and Dupuytren’s contracture, collagenase clostridium histolyticum is used in various medical areas such as wound care, necrotic tissue, burn management, and pain management. In addition to this, over the past few years, an increase has been witnessed in the number of clinical studies, especially in developed countries, focused on discovering other usages of collagenase in human healthcare. Therefore, its widening scope of applications is providing a fillip to the global collagenase clostridium histolyticum market. The market is thriving due to the lack of other standard and reliable medicines and therapies for the treatment of Dupuytren’s contracture and Peyronie’s disease.

On the other hand, the presence of stringent regulatory approval framework and high prices of collagenase are acting as stumbling blocks for the global collagenase clostridium histolyticum market. Moreover, a raft of side effects is associated with the use of collagenase clostridium histolyticum. They include, itching on the treated hand, blisters at the site of injection, painful sexual intercourses, painful erection, and swollen and painful glands in the area around elbow and underarms. However, increasing research and development activities for the introduction of safer drugs and therapies are likely to unfold tremendous growth opportunities for the global collagenase clostridium histolyticum market.

Global Collagenase Clostridium Histolyticum Market: Geographical Segmentation

In terms of geography, the report divides the global biofuels market into Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. North America will be a prominent market for collagenase clostridium histolyticum, thanks to high awareness among the populace regarding diseases such as Peyronie’s and Dupuytren’s and their medications. Rapid clinical advancements are also contributing to the growth of the region. Europe will also account for a substantial share in the market, owing to the rising prevalence of the aforementioned diseases. The presence of advanced healthcare infrastructure is also responsible for the prominence of both the regions.

Global Collagenase Clostridium Histolyticum Market: Competitive Landscape

The global collagenase clostridium histolyticum market is highly competitive and consolidated in nature owing to the presence of a handful of large players. The majority of key companies are involved in mergers and acquisitions and collaborations to strengthen their position in the market. Players are also paying high attention to clinical advancements in order to provide improved and safer drugs. Some of the prominent participants in the global collagenase clostridium histolyticum market are Healthpoint Ltd., BioSpecifics Technologies Corp., Auxilium Pharmaceuticals Inc., Actelion Pharmaceuticals Canada Inc, Smith & Nephew Plc., Advanced Biofactures Corporation, and Swedish Orphan Biovitrum AB.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4474

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Hemostasis Diagnostics Market Share by Industry Research 2016 – 2024

Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has gained a prominent position in the field of medicine and health care.

Rising global prevalence of hemophilia A and B, the most common inherited bleeding disorders, significant surge in a variety of surgeries and trauma patients, and increasing use of recombinant products are the factors likely to drive the hemostasis diagnostics market in the near future. The rapid rate of introduction of cost effective and biodegradable products in the global market is also aiding the growth of the market. Growth across cost-sensitive emerging markets is essentially due to easy availability of cost-effective products. However, saturation of the global hemostasis market and high cost structures of advanced hemostasis products are hampering the growth of the market.

Obtain Report Details @
http://www.transparencymarketresearch.com/hemostasis-diagnostics-market.html

The hemostasis diagnostics market has been segmented based on product type, end-user, and region. Based on product type, the hemostasis diagnostics market has been segmented into analyzers, reagents, and consumables. Analyzers can be further segmented into fully automated analyzers and semi-automated analyzers. Accuracy of hematology analyzers has been enhanced by automation of systems and use of cell surface marker labels. Automated analyzers function by sampling the blood and classifying cell populations by quantification and description. This may be carried out using both electrical and optical techniques. Sophisticated hematology blood cell analyzers are enabling precise disease diagnosis at an early stage. Fully-automated systems compact in size, easy to use, providing networking solutions, and efficient data management have increased adoption of hematology analyzers. In terms of end-user, the hemostasis diagnostics market has been segmented into hospitals, clinical testing laboratories, research & academic institutes, and others.

Hematology instruments and reagents continue to maintain strong position in the health care industry. Market players are making significant investment in product development to offer user-friendly, more sophisticated, efficient, and accurate analyzers to meet the demands of hospitals and clinics. Automated systems play a crucial role in transfusion medicines and facilitate screening of blood donors as well as quality control of blood products.

Geographically, the hemostasis diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global hemostasis diagnostics market owing to the rising installed instrument base leading to higher sales of reagents and support services in the U.S. Beckman Coulter is the market leader in hematology analyzers in the U.S.; however, it faces continuous competition from Sysmex products. The hemostasis diagnostics market in Europe is expected to be driven by steady rise in geriatric population which would boost demand for hemostasis. The vast and continuously rising set of under-served population suffering from bleeding disorders such as hemophilia, especially across developing economies such as India, is expected to boost the adoption of hemostasis products in Asia Pacific. Emerging markets such as India, China, and Brazil are registering significant growth due to increasing population, rise in health care expenditure and higher affordability, economic development, and improving technical capabilities by these countries.

Major players operating in the hemostasis diagnostics market include Abbott Laboratories, Becton, Dickinson and Company, Grifols, S.A, Alere, Inc., F. Hoffmann-La Roche AG, Siemens Healthineers, and Beckman Coulter, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1503

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Community Acquired Pneumonia Market – Global Industry Analysis and Forecast 2016 – 2024

Global Community Acquired Pneumonia (CAP) Market: Overview

Community-acquired pneumonia (CAP) has been a leading cause of mortality among people with infectious diseases and affects people of all age groups. CAP is mainly bacterial in nature and can be caused by a wide range of microorganisms; the most common being streptococcus pneumoniae (pneumococcus). Other pathogens include Haemophilus influenzae, mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella sp.

Increasing prevalence of specific risk factors for CAP in patients has contributed to rising incidence of the infection across various regions. The infection accounts for a significant number of hospital admissions every year. Fuelled by substantial economic and clinical burden of the infection worldwide, a host of treatment modalities to manage CAP has recently emerged. They focus on managing antimicrobial resistance for the most common pathogens, particularly among geriatric population, and evaluating the various vaccination options to prevent these infections. In addition, advancement in diagnostic technologies has increased awareness related to disease incidence, especially in developed nations, thereby fuelling the growth of the market.

The report offers in-depth insight into the key drivers and restraints, current diagnostic trends, emerging treatment modalities, regulatory landscape, market share and size of major segments, and competitive landscape. The strategically motivated insights help various stakeholders gain a better understanding of the market dynamics and identify imminent investment pockets.

Obtain Report Details @
http://www.transparencymarketresearch.com/community-acquired-pneumonia-market.html

Global Community Acquired Pneumonia (CAP) Market: Trends and Opportunities

Rising prevalence of CAP across various regions and the increasing awareness regarding the related diagnostics and therapeutics are the key factors propelling the market. An expanding ageing population, especially in developed countries, is associated with comorbid disease conditions, which has stimulated the demand for advanced CAP treatments. In addition, the concomitant incidence of human immunodeficiency virus (HIV) infection among adult population has increased the morbidity of CAP in some regions, catalyzing the market growth.

However, the rising case of antibiotic-resistant pathogens has hindered the efficacy of antimicrobial treatments and vaccines. This is likely to impede the growth of the market to an extent. Nevertheless, numerous clinical studies in understanding the etiology of the infection and the launch of new biomarkers that help in better risk stratification of patients affected by CAP are crucial developments creating promising opportunities for market players. In addition, the release of the newer pneumococcal conjugate vaccines is anticipated to expand the treatment modalities of CAP.

Global Community Acquired Pneumonia (CAP) Market: Regional Outlook

Europe and North America are prominent markets for community acquired pneumonia. The growth of the regional markets is expected to be driven by robust healthcare infrastructure and increasing awareness about the availability of advanced biomarkers and diagnostic tests. The advent of new treatment therapies, including vaccines, is anticipated to boost the regional market.

Meanwhile, Asia Pacific is expected to expand at an impressive CAGR over the forecast period. Expanding healthcare infrastructure, driven by booming medical tourism in developed and developing countries, and substantial government funding to augment healthcare facilities are the key factors spurring the demand for CAP treatments in Asia Pacific. Furthermore, increasing discretionary spending on healthcare in various countries is expected to propel the Asia Pacific market in the coming years.

Companies mentioned in the report

Major players operating in the CAP market include KYORIN Pharmaceutical Co. Ltd., AstraZeneca Plc, BioAegis Therapeutics, Inc., Biotest AG, and Pfizer Inc. Key strategies adopted by companies to consolidate their presence across major regions are mergers and acquisitions, partnerships, and collaborations.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4314

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/